Clinical Trials
786 trialsA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
DOTA-STR-17126
Integrated Haematology and Oncology Network
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
National Institutes of Health Clinical Center (CC)
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Alterome Therapeutics, Inc.
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
St. Jude Children's Research Hospital
Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction
Barretos Cancer Hospital
FOCUS
Ohio State University Comprehensive Cancer Center
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
Amgen
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
A Study of DEG6498 in Participants With Solid Tumors
Degron Therapeutics Co.
CISTO
University of Washington
SABRE
Boston Scientific Corporation
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
SELECT
University of Manchester
LONGEVITI
University of Alberta
CASSETTE
University of Southampton
EV-309
Astellas Pharma Inc
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.
University of Alicante
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Unity Health Toronto
AxeCan
HealthPartners Institute
ReplaceCysto
White River Junction Veterans Affairs Medical Center
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Agriculture Health Study
National Institutes of Health Clinical Center (CC)
LIAM Mc
University College Cork
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
UNC Lineberger Comprehensive Cancer Center
Indocyanine Green (ICG) Guided Tumor Resection
St. Jude Children's Research Hospital
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
Endocyte
BASECAMP-1
A2 Biotherapeutics Inc.
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
FC-VE
University Hospital, Linkoeping
CARE Tool Study Aim 3
Washington University School of Medicine
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
ELEPHAS-02
Elephas
FRISC
Centre Hospitalier Universitaire, Amiens
PATH
VA Office of Research and Development
P300
Pathos AI, Inc.
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
National Institutes of Health Clinical Center (CC)
CLIQQC
Société Algérienne de Formation et Recherche en Oncologie
AH-HA
Wake Forest University Health Sciences